Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-19-005225
Filing Date
2019-08-07
Accepted
2019-08-07 08:01:20
Documents
55
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_080819p.htm 10-Q 573646
2 EXHIBIT 31.1 exh_311.htm EX-31.1 12203
3 EXHIBIT 31.2 exh_312.htm EX-31.2 11935
4 EXHIBIT 32.1 exh_321.htm EX-32.1 6369
  Complete submission text file 0001171843-19-005225.txt   3058608

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE prto-20190630.xml EX-101.INS 504353
6 XBRL SCHEMA FILE prto-20190630.xsd EX-101.SCH 37147
7 XBRL CALCULATION FILE prto-20190630_cal.xml EX-101.CAL 26062
8 XBRL DEFINITION FILE prto-20190630_def.xml EX-101.DEF 259299
9 XBRL LABEL FILE prto-20190630_lab.xml EX-101.LAB 220370
10 XBRL PRESENTATION FILE prto-20190630_pre.xml EX-101.PRE 280977
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Filer) CIK: 0001359931 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36694 | Film No.: 191003875
SIC: 2836 Biological Products, (No Diagnostic Substances)